SYS-CON MEDIA Authors: Michael Bushong, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Geron Corporation Stockholders Encouraged to Contact Securities Law Firm about Investigation

DALLAS, March 24, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Geron Corporation (NASDAQ: GERN). Concerned GERN investors who purchased between June 16, 2013 and March 11, 2014 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

"After the March 12, 2014 announcement that the FDA put Geron's Investigational New Drug application for imetelstat on full clinical hold, stock plummeted more than 60%," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed to Geron Corporation shareholders." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. GERN stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
[email protected]
www.deanslyons.com

SOURCE Deans & Lyons LLP

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.